Stocks / MRNA / Gross Profit

Moderna, Inc. Gross Profit 2016–2025

Moderna, Inc. reported $1.08B of gross profit for fiscal 2025. That was 39.3% lower than fiscal 2024. Compared with fiscal 2020, the change was +35.3%.

Latest filed value
$1.08B
One-year change
-39.3%
Change since 2020
+35.3%
Latest period end
2025
Moderna, Inc. Gross Profit history from 2020 to 2025FY 2020: 795000000FY 2021: 15854000000FY 2022: 13847000000FY 2023: 2155000000FY 2024: 1772000000FY 2025: 1076000000
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearGross ProfitGross marginChange (YoY)
FY 2025$1.08B55.3%-39.3%
FY 2024$1.77B54.8%-17.8%
FY 2023$2.15B31.5%-84.4%
FY 2022$13.85B71.9%-12.7%
FY 2021$15.85B85.8%+1894.2%
FY 2020$795.00M99.0%
FY 2019
FY 2018
FY 2017
FY 2016

Source: Moderna, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open MRNA 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Moderna, Inc. reported $1.08B of gross profit for fiscal 2025. That was 39.3% lower than fiscal 2024. Compared with fiscal 2020, the change was +35.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Moderna, Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Moderna, Inc. — frequently asked questions

What is Moderna, Inc.'s gross profit?

Moderna, Inc. (MRNA) reported gross profit of $1.08B for fiscal year 2025, per its SEC filings.

How has Moderna, Inc.'s gross profit changed over time?

Between fiscal 2016 and 2025, MRNA's gross profit grew at roughly 3.4% per year (compound annual rate), from $795.00M to $1.08B.

Where does this data come from?

Figures are computed from Moderna, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.

More MRNA financial history

Full MRNA fundamentals page → · Analyze gross profit with a free tool → · All 1,500+ companies →